Citations 19
Faculty Opinions recommendation of MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax).
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.
Meng, Wei , Kaufmann, Scott H. , Dai, Haiming
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective pharmacological inhibition of prosurvival Bcl-2 with ABT-199.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Antagonism of Bcl-XL is necessary for synergy between carboplatin and BH3 mimetics in ovarian cancer cells.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Bcl-xL mediates therapeutic resistance of a mesenchymal breast cancer cell subpopulation.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available
Faculty Opinions recommendation of Discovery of a Potent and Selective BCL-XL Inhibitor with in Vivo Activity.
Meng, Wei , Kaufmann, Scott H.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | November 17, 2016 | Volume: No volume available | Issue: No issue available | Pages: No page available